170 related articles for article (PubMed ID: 6737078)
1. Potential of palladium-109-labeled antimelanoma monoclonal antibody for tumor therapy.
Fawwaz RA; Wang TS; Srivastava SC; Rosen JM; Ferrone S; Hardy MA; Alderson PO
J Nucl Med; 1984 Jul; 25(7):796-9. PubMed ID: 6737078
[TBL] [Abstract][Full Text] [Related]
2. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.
Hwang KM; Fodstad O; Oldham RK; Morgan AC
Cancer Res; 1985 Sep; 45(9):4150-5. PubMed ID: 4028007
[TBL] [Abstract][Full Text] [Related]
3. Suppression of human melanoma growth in nude mice injected with anti high-molecular-weight melanoma-associated antigen monoclonal antibody 225.28S conjugated to purothionin.
Matsui M; Nakanishi T; Noguchi T; Imai K; Yachi A; Ferrone S
Jpn J Cancer Res; 1985 Feb; 76(2):119-23. PubMed ID: 3920101
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
5. Potential of palladium-109-labeled antimelanoma monoclonal antibody for tumor therapy.
Wahl RL
J Nucl Med; 1985 Feb; 26(2):208-9. PubMed ID: 3968583
[No Abstract] [Full Text] [Related]
6. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
7. Radiolocalization of 99mTc-labeled fragments in a melanoma xenografted model.
Paganelli G; Viale G; Rossetti C; Magnani P; Sudati F; Vanoli G; Seccamani E; Palmucci F; Fazio F
J Nucl Biol Med (1991); 1991; 35(1):41-6. PubMed ID: 1932175
[TBL] [Abstract][Full Text] [Related]
8. Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.
Murray JL; Zukiwski AA; Mujoo K; Rosenblum MG
J Biol Response Mod; 1990 Dec; 9(6):556-63. PubMed ID: 2074442
[TBL] [Abstract][Full Text] [Related]
9. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
10. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.
Kang N; Hamilton S; Odili J; Wilson G; Kupsch J
Clin Cancer Res; 2000 Dec; 6(12):4921-31. PubMed ID: 11156253
[TBL] [Abstract][Full Text] [Related]
11. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.
Wilbur DS; Hadley SW; Hylarides MD; Abrams PG; Beaumier PA; Morgan AC; Reno JM; Fritzberg AR
J Nucl Med; 1989 Feb; 30(2):216-26. PubMed ID: 2738650
[TBL] [Abstract][Full Text] [Related]
12. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
[TBL] [Abstract][Full Text] [Related]
13. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft.
Katano M; Saxton RE; Tsuchida T; Irie RF
Jpn J Cancer Res; 1986 Jun; 77(6):584-94. PubMed ID: 3089993
[TBL] [Abstract][Full Text] [Related]
14. Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody.
Colcher D; Zalutsky M; Kaplan W; Kufe D; Austin F; Schlom J
Cancer Res; 1983 Feb; 43(2):736-42. PubMed ID: 6848189
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
16. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
17. Biologic characterization of melanoma tumors by antigen-specific targeting of radiolabeled anti-tumor antibodies.
Larson SM
J Nucl Med; 1991 Feb; 32(2):287-91. PubMed ID: 1992033
[No Abstract] [Full Text] [Related]
18. Variables influencing tumor uptake of anti-melanoma monoclonal antibodies radioiodinated using para-iodobenzoyl (PIB) conjugate.
Murray JL; Mujoo K; Wilmanns C; Mansfield P; Wilbur DS; Rosenblum MG
J Nucl Med; 1991 Feb; 32(2):279-87. PubMed ID: 1992032
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts.
Hamby CV; Liao SK; Kanamaru T; Ferrone S
Cancer Res; 1987 Oct; 47(20):5284-9. PubMed ID: 3115563
[TBL] [Abstract][Full Text] [Related]
20. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
